ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Psmp is Discriminative for Chronic Active Antibody-Mediated Rejection and Predicts Graft Risk After Kidney Transplantation

Y. Fu, P. Zhan

Tianjin First Central Hospital, Tianjin, China

Meeting: 2021 American Transplant Congress

Abstract number: 1046

Keywords: Fibrosis, High-risk, Kidney transplantation, Rejection

Topic: Clinical Science » Kidney » Kidney Chronic Antibody Mediated Rejection

Session Information

Session Name: Kidney Chronic Antibody Mediated Rejection

Session Type: Poster Abstract

Session Date & Time: None. Available on demand.

Location: Virtual

*Purpose: Chronic active antibody-mediated rejection (c-aABMR) is an intermediate process in the development of chronic antibody-mediated rejection (c-ABMR), a key problem in the long-term failure of kidney graft. PC3-secreted microprotein (PSMP), a new chemotactic cytokine recruiting macrophages, enhances fibrosis progression. However, the relationship between PSMP and chronic active antibody-mediated rejection (c-aABMR) in kidney transplantation need to be further explored. This study was to investigate the role PSMP playing on the progression of c-aABMR and c-ABMR.

*Methods: In this study, a total of 29 kidney transplant recipients were included and classified into chronic active antibody-mediated rejection (c-aABMR) group (n=14), chronic antibody-mediated rejection (c-ABMR) group (n=5) and normal function group (n=10) according to their allograft biopsy pathology diagnosis. Patients demographics, kidney allograft biopsy sample fibrosis stained with HE and masson, immunohistochemistry staining of PSMP and CD68, PSMP gene-expression quantitated by real time RT-PCR and the serum and urine PSMP level were compared between three groups. The serum and urine PSMP expressions were detected by ELISA.

*Results: Patients demographics results of three groups were no difference. Compared with normal groups, the allograft survival rate of c-aABMR group was significantly low (58.3% vs. 0%). Pathologic Banff scrores of three groups showed that c-aABMR group had more severe peritubular capillaritis (PTC) and tubulitis inflammation (t). Moreover,there was more fibrosis area and eGFR declined in both c-aABMR and c-ABMR groups, but no difference between the two groups. While CD68 expression was highest in c-aABMR among three groups, which was significantly positive associated with fibrosis grade in c-aABMR. Consistent with the CD68 expression, PSMP expression was significance higher in c-aABMR group than c-ABMR and normal groups. A significant correlation was found between the expression between CD68 and PSMP in c-aABMR, PSMP high expressed grafts had significantly higher t, i, c4d score and more allograft function loss compared to PSMP low expressed grafts. In addition, we found that urinary PSMP may be a candidate molecule marker for c-aABMR. Indeed, urinary PSMP concentration was significantly higher in kidney grafts pathologically diagnosed with c-aABMR than c-ABMR and normal counterparts, while no clear trend in serum. Indeed, urinary PSMP concentration was significantly higher in kidney grafts pathologically diagnosed with c-aABMR than c-ABMR and normal counterparts, while no clear trend in serum.

*Conclusions: PSMP level was associated with macrophages infiltrating and fibrosis in c-aABMR which could be a promising biomarker to distinguish and predict risks of c-aABMR allograft lost.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Fu Y, Zhan P. Psmp is Discriminative for Chronic Active Antibody-Mediated Rejection and Predicts Graft Risk After Kidney Transplantation [abstract]. Am J Transplant. 2021; 21 (suppl 3). https://atcmeetingabstracts.com/abstract/psmp-is-discriminative-for-chronic-active-antibody-mediated-rejection-and-predicts-graft-risk-after-kidney-transplantation/. Accessed May 11, 2025.

« Back to 2021 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences